Quantum Computing Advancing Drug Discovery

Using quantum computing and supercomputer technologies to forward drug discovery According to McKinsey & Company, introducing a new drug to the market takes up to 12 years—a long period influenced by several elements including technology constraints, legal requirements, patient recruitment and retention. More data than ever are produced by increasingly complicated scientific inventions and clinical […]

Pharma 4.0 Revolutionizes Drug Manufacturing

Market for Pharmaceutical Robots Projected to Reach $426.8M by 2031 From small-scale manual production using simple tools to massive operations in today’s multimillion-dollar pharmaceutical industry, medication manufacture has changed dramatically throughout time. Technological developments like robotics, artificial intelligence (AI), and the Internet of Things (IoT), which have substantially enhanced the efficiency, quality, speed, and adaptability […]

Revolutionizing Pharma Manufacturing with Biofermentation

Synthetic Chemistry and Integrated Biofermentation Transformational Pharmaceutical Manufacturing Combining biofermentation with chemical synthesis is shown to be creative in the realm of pharmaceutical manufacturing.  Following industry sustainability and innovation goals, this modern approach raises manufacturing process efficiency.  Businesses, researchers, and developers are urged to mix these two apparently incompatible strategies to save costs, increase operational […]

Asia-Pacific Governments Boost Healthcare Innovation And R&D

Several Asian-Pacific local governments have passed helpful policies and rules in the last five years to improve healthcare and speed up drug research in their own markets. These projects have made it much easier for people in the business to work together. The Focus on R&D It is true that governments are showing a strong […]

Biotech Outsourcing: Trends, CDMO Growth, And Expansion

Outsourcing has become an important part of the biotech business because many contract manufacturing organizations (CMOs) are the only ones that can make the huge amounts of medicines and treatments that are needed. Some other reasons to outsource are to keep costs down and limit internal staff and resources, to get the word out about […]

Advancing Continuous Bioprocessing For Enhanced Productivity

The biopharmaceutical sector is now going through a significant transition toward continuous bioprocessing which is currently taking place. In contrast to the conventional batch processing method, which is characterized by the presence of distinct phases and interim holding tanks, the consistent bioprocessing method functions without any interruptions. Within the confines of a single interconnected system, […]

Generative AI In Pharma: Major Opportunities And Hurdles

Among the pharmaceutical DX-digital transformation professionals, 67% responded that they were not ready when asked about how ready the life sciences sector is to effectively go ahead and leverage generative AI in terms of infrastructure, regulatory considerations, and expertise. This is according to a new report published by Axendia Market Research. A total of 43 […]

Global Biopharma Market To Hit $566B By 2032 Amid Challenges

The value of the global biopharmaceutical industry is expected to rise significantly, from $263 billion in 2022 to $566 billion by 2032, representing a compound annual growth rate of about 8% from 2023 to 2032. This growth is mostly being driven by the rising need for novel therapies, chronic illnesses, and the increasing incidence of […]

CordenPharma Expands Peptide Platform with >€500m Greenfield Facility Construction in the Basel Region of Switzerland

CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, and large peptide manufacturing facilities across Europe and the US. In Switzerland, CordenPharma will invest >€500m to construct a greenfield site for small to large-scale peptide development and manufacturing located within the Basel region in […]

Unlocking New Insights into Neurodegenerative Diseases: The Essential Role of Complex Cell Models and Live-Cell Analysis

Neurodegenerative diseases, like Alzheimer’s, Parkinson’s, and motor neuron diseases such as Amyotrophic Lateral Sclerosis (ALS) and spinal muscular atrophy, have a profound impact on patients and their families. Developing effective treatments for these conditions is faster when we have access to translational models that help identify promising drug candidates for clinical trials. This article provides […]